These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
728 related articles for article (PubMed ID: 24473488)
1. Fondaparinux as alternative anticoagulant to warfarin or low-molecular-weight heparin for recurrent venous thrombosis. Thachil J Ann Pharmacother; 2014 Mar; 48(3):420-4. PubMed ID: 24473488 [TBL] [Abstract][Full Text] [Related]
2. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention. Huisman MV; Bounameaux H Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915 [TBL] [Abstract][Full Text] [Related]
3. Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study. Rahme E; Feugère G; Sirois C; Weicker S; Ramos E Thromb Res; 2013 Mar; 131(3):210-7. PubMed ID: 23290095 [TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism in lymphoma: how effectively are we treating patients? Muslimani AA; Spiro TP; Chaudhry AA; Taylor HC; Daw HA Am J Clin Oncol; 2009 Oct; 32(5):521-3. PubMed ID: 19546801 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry. Donath L; Lützner J; Werth S; Kuhlisch E; Hartmann A; Günther KP; Weiss N; Beyer-Westendorf J Br J Clin Pharmacol; 2012 Dec; 74(6):947-58. PubMed ID: 22515679 [TBL] [Abstract][Full Text] [Related]
6. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Akl EA; Kahale L; Neumann I; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H Cochrane Database Syst Rev; 2014 Jun; (6):CD006649. PubMed ID: 24945634 [TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism in cancer patients. Deng A; Galanis T; Graham MG Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915 [TBL] [Abstract][Full Text] [Related]
8. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. Lee AY; Levine MN; Baker RI; Bowden C; Kakkar AK; Prins M; Rickles FR; Julian JA; Haley S; Kovacs MJ; Gent M; N Engl J Med; 2003 Jul; 349(2):146-53. PubMed ID: 12853587 [TBL] [Abstract][Full Text] [Related]
9. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Akl EA; Vasireddi SR; Gunukula S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H Cochrane Database Syst Rev; 2011 Jun; (6):CD006649. PubMed ID: 21678360 [TBL] [Abstract][Full Text] [Related]
10. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Akl EA; Vasireddi SR; Gunukula S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H Cochrane Database Syst Rev; 2011 Feb; (2):CD006649. PubMed ID: 21328285 [TBL] [Abstract][Full Text] [Related]
11. Update in the treatment of venous thromboembolism. Garcia DA; Spyropoulos AC Semin Respir Crit Care Med; 2008 Feb; 29(1):40-6. PubMed ID: 18302085 [TBL] [Abstract][Full Text] [Related]
12. Successful use of fondaparinux early after mechanical aortic valve replacement in a patient with a history of heparin-induced thrombocytopenia. Willenborg KL Pharmacotherapy; 2014 Jun; 34(6):e55-9. PubMed ID: 24644124 [TBL] [Abstract][Full Text] [Related]
13. Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery. Raskob GE; Hirsh J Chest; 2003 Dec; 124(6 Suppl):379S-385S. PubMed ID: 14668421 [TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients. Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080 [TBL] [Abstract][Full Text] [Related]
15. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial. Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA; JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719 [TBL] [Abstract][Full Text] [Related]
16. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials. van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123 [TBL] [Abstract][Full Text] [Related]
17. Successful use of fondaparinux in a child with heparin-induced thrombocytopenia. Tokgoz H; Caliskan U; Demir M Blood Coagul Fibrinolysis; 2012 Dec; 23(8):769-71. PubMed ID: 22964766 [TBL] [Abstract][Full Text] [Related]
18. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months. Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181 [TBL] [Abstract][Full Text] [Related]
19. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Akl EA; Rohilla S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann HJ Cochrane Database Syst Rev; 2008 Jan; (1):CD006649. PubMed ID: 18254108 [TBL] [Abstract][Full Text] [Related]
20. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P; Behounek J; Skoták M; Nevsímal L Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]